Optimal H1N1 vaccination strategies based on self-interest versus group interest
被引:22
|
作者:
Shim, Eunha
论文数: 0引用数: 0
h-index: 0
机构:
Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15261 USA
Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USAUniv Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15261 USA
Shim, Eunha
[1
,2
]
Meyers, Lauren Ancel
论文数: 0引用数: 0
h-index: 0
机构:
Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA
Santa Fe Inst, Santa Fe, NM 87501 USAUniv Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15261 USA
Meyers, Lauren Ancel
[3
,4
]
Galvani, Alison P.
论文数: 0引用数: 0
h-index: 0
机构:
Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USAUniv Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15261 USA
Galvani, Alison P.
[2
]
机构:
[1] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15261 USA
[2] Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA
Background: Influenza vaccination is vital for reducing H1N1 infection-mediated morbidity and mortality. To reduce transmission and achieve herd immunity during the initial 2009-2010 pandemic season, the US Centers for Disease Control and Prevention (CDC) recommended that initial priority for H1N1 vaccines be given to individuals under age 25, as these individuals are more likely to spread influenza than older adults. However, due to significant delay in vaccine delivery for the H1N1 influenza pandemic, a large fraction of population was exposed to the H1N1 virus and thereby obtained immunity prior to the wide availability of vaccines. This exposure affects the spread of the disease and needs to be considered when prioritizing vaccine distribution. Methods: To determine optimal H1N1 vaccine distributions based on individual self-interest versus population interest, we constructed a game theoretical age-structured model of influenza transmission and considered the impact of delayed vaccination. Results: Our results indicate that if individuals decide to vaccinate according to self-interest, the resulting optimal vaccination strategy would prioritize adults of age 25 to 49 followed by either preschool-age children before the pandemic peak or older adults (age 50-64) at the pandemic peak. In contrast, the vaccine allocation strategy that is optimal for the population as a whole would prioritize individuals of ages 5 to 64 to curb a growing pandemic regardless of the timing of the vaccination program. Conclusions: Our results indicate that for a delayed vaccine distribution, the priorities that are optimal at a population level do not align with those that are optimal according to individual self-interest. Moreover, the discordance between the optimal vaccine distributions based on individual self-interest and those based on population interest is even more pronounced when vaccine availability is delayed. To determine optimal vaccine allocation for pandemic influenza, public health agencies need to consider both the changes in infection risks among age groups and expected patterns of adherence.
机构:
Beijing Ctr Dis Control & Prevent, Beijing, Peoples R ChinaUniv Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Wu, Jiang
Zhong, Xiang
论文数: 0引用数: 0
h-index: 0
机构:
Sinovac Biotech Co Ltd, Beijing, Peoples R ChinaUniv Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Zhong, Xiang
Li, Chris Ka-fai
论文数: 0引用数: 0
h-index: 0
机构:Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Li, Chris Ka-fai
Zhou, Jian-fang
论文数: 0引用数: 0
h-index: 0
机构:
Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Beijing, Peoples R ChinaUniv Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Zhou, Jian-fang
Lu, Min
论文数: 0引用数: 0
h-index: 0
机构:
Beijing Ctr Dis Control & Prevent, Beijing, Peoples R ChinaUniv Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Lu, Min
Huang, Kuan-Ying
论文数: 0引用数: 0
h-index: 0
机构:Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Huang, Kuan-Ying
Dong, Mei
论文数: 0引用数: 0
h-index: 0
机构:
Beijing Ctr Dis Control & Prevent, Beijing, Peoples R ChinaUniv Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Dong, Mei
Liu, Yan
论文数: 0引用数: 0
h-index: 0
机构:
Sinovac Biotech Co Ltd, Beijing, Peoples R ChinaUniv Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Liu, Yan
Luo, Feng-Ji
论文数: 0引用数: 0
h-index: 0
机构:Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Luo, Feng-Ji
Du, Ning
论文数: 0引用数: 0
h-index: 0
机构:
Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Beijing, Peoples R ChinaUniv Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Du, Ning
Chui, Cecilia
论文数: 0引用数: 0
h-index: 0
机构:Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Chui, Cecilia
Liu, Li-Qi
论文数: 0引用数: 0
h-index: 0
机构:
Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Beijing, Peoples R ChinaUniv Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Liu, Li-Qi
Smith, Nicola M. G.
论文数: 0引用数: 0
h-index: 0
机构:Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Smith, Nicola M. G.
Li, Bo
论文数: 0引用数: 0
h-index: 0
机构:
Capital Med Univ, Dept Immunol, Beijing, Peoples R ChinaUniv Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Li, Bo
Shi, Nian-Min
论文数: 0引用数: 0
h-index: 0
机构:Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Shi, Nian-Min
Song, Li-Fei
论文数: 0引用数: 0
h-index: 0
机构:
Sinovac Biotech Co Ltd, Beijing, Peoples R ChinaUniv Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Song, Li-Fei
Gao, Yan
论文数: 0引用数: 0
h-index: 0
机构:
Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Beijing, Peoples R ChinaUniv Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Gao, Yan
Wang, Da-Yan
论文数: 0引用数: 0
h-index: 0
机构:
Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Beijing, Peoples R ChinaUniv Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Wang, Da-Yan
Wang, Xu
论文数: 0引用数: 0
h-index: 0
机构:
Sinovac Biotech Co Ltd, Beijing, Peoples R ChinaUniv Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Wang, Xu
Zhu, Wen-Fei
论文数: 0引用数: 0
h-index: 0
机构:
Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Beijing, Peoples R ChinaUniv Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Zhu, Wen-Fei
Yan, Yan
论文数: 0引用数: 0
h-index: 0
机构:
Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Beijing, Peoples R ChinaUniv Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Yan, Yan
Li, Zi
论文数: 0引用数: 0
h-index: 0
机构:
Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Beijing, Peoples R ChinaUniv Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Li, Zi
Chen, Jiang-Ting
论文数: 0引用数: 0
h-index: 0
机构:
Sinovac Biotech Co Ltd, Beijing, Peoples R ChinaUniv Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Chen, Jiang-Ting
McMichael, Andrew J.
论文数: 0引用数: 0
h-index: 0
机构:Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
McMichael, Andrew J.
Yin, Wei-Dong
论文数: 0引用数: 0
h-index: 0
机构:
Sinovac Biotech Co Ltd, Beijing, Peoples R ChinaUniv Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Yin, Wei-Dong
Xu, Xiao-Ning
论文数: 0引用数: 0
h-index: 0
机构:
Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, EnglandUniv Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
Xu, Xiao-Ning
Shu, Yuelong
论文数: 0引用数: 0
h-index: 0
机构:
Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Beijing, Peoples R ChinaUniv Oxford, John Radcliffe Hosp, Weatherall Inst Mol Medicine, MRC Human Immunol Unit, Oxford OX3 9DS, England
机构:
Hosp Madre Teresa, Belo Horizonte, MG, BrazilHosp Madre Teresa, Belo Horizonte, MG, Brazil
Studart Gurgel Mendes, Mirian Fabiola
Valladares Neto, Dirceu de Campos
论文数: 0引用数: 0
h-index: 0
机构:
Fundacao Nacl Sono, Clin Sono, Nova Lima, MG, BrazilHosp Madre Teresa, Belo Horizonte, MG, Brazil
Valladares Neto, Dirceu de Campos
de Azevedo, Rosangela Aparecida
论文数: 0引用数: 0
h-index: 0
机构:
Secretaria Estado Saude Sao Paulo, Sistema Informacoes Efeitos Adversos Posvacinais, Coordenacao Imunizacoes, Belo Horizonte, MG, BrazilHosp Madre Teresa, Belo Horizonte, MG, Brazil
de Azevedo, Rosangela Aparecida
Caramelli, Paulo
论文数: 0引用数: 0
h-index: 0
机构:
Univ Fed Minas Gerais, Fac Med, Dept Clin Med, Belo Horizonte, MG, BrazilHosp Madre Teresa, Belo Horizonte, MG, Brazil